Compare Stocks

→ Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COG Cabot Oil & Gas		$17.89	$14.28 ▼ $23.10	$8.89B	0.15	8.21 million shs	1.24 million shs
ONC Oncolytics Biotech	C$1.44 +0.7%	C$1.44	C$1.20 ▼ C$4.49	C$108.61M	1.49	79,339 shs	23,577 shs
VPT VentriPoint Diagnostics	C$0.22 +2.4%	C$0.25	C$0.12 ▼ C$0.36	C$33.72M	0.39	99,409 shs	81,500 shs

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COG Cabot Oil & Gas	0.00%	0.00%	0.00%	0.00%	0.00%
ONC Oncolytics Biotech	+0.70%	-6.49%	+4.35%	-11.11%	-7.10%
VPT VentriPoint Diagnostics	+2.38%	+2.38%	-10.42%	-28.33%	+26.47%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COG Cabot Oil & Gas	0.7854 of 5 stars	0.0	0.0	1.7	0.0	0.6	0.0	3.8
ONC Oncolytics Biotech	0.6498 of 5 stars	3.5	0.0	0.0	0.0	1.3	0.0	0.0
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COG Cabot Oil & Gas	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	3.00	Buy	C$6.00	316.67% Upside
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest YGEN, VRCI, VPT, COG, and ONC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/4/2024	ONC Oncolytics Biotech	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform	C$3.00

(Data available from 4/20/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COG Cabot Oil & Gas	$1.47B	0.00	N/A	12.93	$5.56 per share	0.00
ONC Oncolytics Biotech	N/A	N/A	C$0.34 per share	4.22	C$0.37 per share	N/A
VPT VentriPoint Diagnostics	C$24.60K	1,370.58	C$0.04 per share	5.53	C$0.01 per share	21.50

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COG Cabot Oil & Gas	$200.53M	$0.43	28.90	0.00	0.19	19.77%	16.52%	8.16%	N/A
ONC Oncolytics Biotech	-C$27.75M	-C$0.41	N/A	∞	N/A	N/A	-102.66%	-55.47%	5/3/2024 (Estimated)
VPT VentriPoint Diagnostics	-C$4.74M	-C$0.03	N/A	∞	N/A	N/A	-141.63%	-63.46%	5/2/2024 (Estimated)

Latest YGEN, VRCI, VPT, COG, and ONC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/7/2024	Q4 2023	ONC Oncolytics Biotech	-C$0.15	-C$0.05	+C$0.10	-C$0.05	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COG Cabot Oil & Gas	$0.44	N/A	N/A	102.33%	N/A
ONC Oncolytics Biotech	N/A	N/A	N/A	N/A	N/A
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COG Cabot Oil & Gas	0.41	1.05	1.00
ONC Oncolytics Biotech	1.54	9.01	8.86
VPT VentriPoint Diagnostics	32.61	2.06	6.67

Ownership

Institutional Ownership

Company	Institutional Ownership
COG Cabot Oil & Gas	N/A
ONC Oncolytics Biotech	6.98%
VPT VentriPoint Diagnostics	N/A

Insider Ownership

Company	Insider Ownership
COG Cabot Oil & Gas	2.10%
ONC Oncolytics Biotech	6.24%
VPT VentriPoint Diagnostics	1.93%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COG Cabot Oil & Gas	503	399.66 million	N/A	Optionable
ONC Oncolytics Biotech	29	75.42 million	N/A	Not Optionable
VPT VentriPoint Diagnostics	147,000	156.82 million	N/A	Not Optionable

YGEN, VRCI, VPT, COG, and ONC Headlines

Source	Headline
	VentriPoint Diagnostics (CVE:VPT) Trading Up 4.8% americanbankingnews.com - April 17 at 1:50 AM
	VentriPoint Diagnostics Ltd VPT morningstar.com - April 14 at 8:55 AM
	Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call finance.yahoo.com - March 28 at 10:36 AM
	Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use stockhouse.com - March 4 at 1:29 PM
	VentriPoint Diagnostics Stock (OTC:VPTDF) Dividends: History, Yield and Dates benzinga.com - February 21 at 6:59 PM
	Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences thenewswire.com - February 20 at 3:23 PM
	VentriPoint Diagnostics Ltd VPTDF morningstar.com - February 14 at 8:46 AM
	Ventripoint Announces Changes to The Board of Directors thenewswire.com - February 13 at 3:04 PM
	Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales stockhouse.com - February 13 at 10:03 AM
	The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System es-us.finanzas.yahoo.com - February 1 at 12:00 PM
	The 2023 Year in Review finance.yahoo.com - January 29 at 2:50 PM
	Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board thenewswire.com - January 22 at 1:13 AM
	Ventripoint Whitepaper Distribution: thenewswire.com - January 3 at 1:30 PM
	Healthcare Stock Rallies Strongly Following Key Implementation theglobeandmail.com - December 12 at 3:45 PM
	Ollie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's Hospitals finance.yahoo.com - December 5 at 9:22 AM
	Editorial: EV diagnostic process should become industry standard autonews.com - November 21 at 11:55 PM
	In 2026, EVs will have an industry standard diagnostic system autonews.com - November 14 at 9:07 PM
	Ventripoint to Demonstrate AI-powered Heart Imaging Technology at The British Congenital Cardiac Association Annual Conference thenewswire.com - November 9 at 8:59 AM
	Accelerate Diagnostics Inc AXDX morningstar.com - November 5 at 6:39 PM
	Quest Diagnostics Reviews consumeraffairs.com - October 15 at 6:11 PM
	Ventripoint AI Heart Imaging Technology To Be Presented at British Society of Echocardiography Annual Conference thenewswire.com - October 12 at 10:38 AM
	Ventripoint Diagnostics appoints Jimmy Jeon as CFO seekingalpha.com - October 4 at 2:44 PM
	Ventripoint Announced as Gold Sponsor for the 8th Annual Paediatric Echo Society Symposium thenewswire.com - September 8 at 2:16 PM
	VentriPoint Diagnostics reports Q2 results seekingalpha.com - August 31 at 3:05 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cabot Oil & Gas

NYSE:COG

Cabot Oil & Gas Corp. engages in the development, exploitation, production and exploration of oil and natural gas properties. It operates through the Marcellus shale in Pennsylvania. The company was founded in 1989 and is headquartered in Houston, TX.

Oncolytics Biotech

TSE:ONC

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and Bavencio, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

VentriPoint Diagnostics

CVE:VPT

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial